Cargando…

Outcome of COVID-19 Infection in Cancer Patients in Pune

Introduction  We document our data on the course of the coronavirus disease 2019 (COVID-19) infection in cancer patients in an attempt to help optimize their management in India and globally. Material and Methods  Between February 2020 and January 2021, participating oncologists from Pune (members o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hingmire, Sachin, Wategaonkar, Ravikumar, Hegde, Sujai, Mekha, Mangesh, Kulkarni, Rahul, Rajbhoj, Ashwin, Deshmukh, Chetan, Kulkarni, Padmaj, Patil, Tushar, Kanitkar, Gajanan, Wanjarkhedkar, Pankaj, Mane, Anupama, Bokil, Kamlesh, Parasnis, Amit, Gawande, Jayant, Bhatia, Jatin, Khaladkar, Bhagyashree, Sirsath, Nagesh, Melinkeri, Sameer, Kashyapi, Bhalchandra, Agrawal, Rakesh Kumar, Prabhakaran, Anushree, Desai, Isha, Kelkar, Dhananjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380150/
https://www.ncbi.nlm.nih.gov/pubmed/34430515
http://dx.doi.org/10.1055/s-0041-1731910
_version_ 1783741140762099712
author Hingmire, Sachin
Wategaonkar, Ravikumar
Hegde, Sujai
Mekha, Mangesh
Kulkarni, Rahul
Rajbhoj, Ashwin
Deshmukh, Chetan
Kulkarni, Padmaj
Patil, Tushar
Kanitkar, Gajanan
Wanjarkhedkar, Pankaj
Mane, Anupama
Bokil, Kamlesh
Parasnis, Amit
Gawande, Jayant
Bhatia, Jatin
Khaladkar, Bhagyashree
Sirsath, Nagesh
Melinkeri, Sameer
Kashyapi, Bhalchandra
Agrawal, Rakesh Kumar
Prabhakaran, Anushree
Desai, Isha
Kelkar, Dhananjay
author_facet Hingmire, Sachin
Wategaonkar, Ravikumar
Hegde, Sujai
Mekha, Mangesh
Kulkarni, Rahul
Rajbhoj, Ashwin
Deshmukh, Chetan
Kulkarni, Padmaj
Patil, Tushar
Kanitkar, Gajanan
Wanjarkhedkar, Pankaj
Mane, Anupama
Bokil, Kamlesh
Parasnis, Amit
Gawande, Jayant
Bhatia, Jatin
Khaladkar, Bhagyashree
Sirsath, Nagesh
Melinkeri, Sameer
Kashyapi, Bhalchandra
Agrawal, Rakesh Kumar
Prabhakaran, Anushree
Desai, Isha
Kelkar, Dhananjay
author_sort Hingmire, Sachin
collection PubMed
description Introduction  We document our data on the course of the coronavirus disease 2019 (COVID-19) infection in cancer patients in an attempt to help optimize their management in India and globally. Material and Methods  Between February 2020 and January 2021, participating oncologists from Pune (members of the Oncology Group of Pune) documented effect of COVID-19 infection in their cancer patients. Binomial logistic regression analysis as well as correlation analysis was done using Pearson Chi-square test to determine significance of clinical factors. Results  A total of 29 oncologists from 20 hospitals contributed their data involving 147 cancer patients who developed COVID-19 infections. COVID-19 infection resulted in higher deaths (likelihood ratio of 4.4) amongst patients with hematological malignancies (12/44 = 27.2%) as compared with those with solid tumors (13/90 = 14.4%, p = 0.030). Patients with uncontrolled or progressive cancer (11/34 = 32.4%) when they got infected with COVID-19 had higher mortality as compared with patients whose cancer was under control (14/113 = 12.4%; p = 0.020). Complication of thromboembolic episodes (seen in eight patients; 5.4% cases) was associated with higher risk (25.6 times) of death (five-eighths; 62.5%) as compared with those who did not develop it (20/139;14.4%; p <0.001). Discussion  Patients with cancer should be advised to take strict precautions to reduce the risk of being infected with COVID-19. They should also be given priority for COVID-19 vaccination. If infected with COVID-19, patients with hematological malignancy and uncontrolled cancer are at higher risk of morbidity and mortality. When they are being treated (OPD or inpatient basis), additional precautions are necessary to ensure their exposure to potential COVID-19 virus is minimized. If they get infected with COVID-19, they should be given aggressive treatment to prevent complications, especially thromboembolic episodes. If they develop any thromboembolic complication, their risk of dying are significantly higher, and management should be modified accordingly.
format Online
Article
Text
id pubmed-8380150
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Thieme Medical and Scientific Publishers Private Ltd
record_format MEDLINE/PubMed
spelling pubmed-83801502021-08-23 Outcome of COVID-19 Infection in Cancer Patients in Pune Hingmire, Sachin Wategaonkar, Ravikumar Hegde, Sujai Mekha, Mangesh Kulkarni, Rahul Rajbhoj, Ashwin Deshmukh, Chetan Kulkarni, Padmaj Patil, Tushar Kanitkar, Gajanan Wanjarkhedkar, Pankaj Mane, Anupama Bokil, Kamlesh Parasnis, Amit Gawande, Jayant Bhatia, Jatin Khaladkar, Bhagyashree Sirsath, Nagesh Melinkeri, Sameer Kashyapi, Bhalchandra Agrawal, Rakesh Kumar Prabhakaran, Anushree Desai, Isha Kelkar, Dhananjay South Asian J Cancer Introduction  We document our data on the course of the coronavirus disease 2019 (COVID-19) infection in cancer patients in an attempt to help optimize their management in India and globally. Material and Methods  Between February 2020 and January 2021, participating oncologists from Pune (members of the Oncology Group of Pune) documented effect of COVID-19 infection in their cancer patients. Binomial logistic regression analysis as well as correlation analysis was done using Pearson Chi-square test to determine significance of clinical factors. Results  A total of 29 oncologists from 20 hospitals contributed their data involving 147 cancer patients who developed COVID-19 infections. COVID-19 infection resulted in higher deaths (likelihood ratio of 4.4) amongst patients with hematological malignancies (12/44 = 27.2%) as compared with those with solid tumors (13/90 = 14.4%, p = 0.030). Patients with uncontrolled or progressive cancer (11/34 = 32.4%) when they got infected with COVID-19 had higher mortality as compared with patients whose cancer was under control (14/113 = 12.4%; p = 0.020). Complication of thromboembolic episodes (seen in eight patients; 5.4% cases) was associated with higher risk (25.6 times) of death (five-eighths; 62.5%) as compared with those who did not develop it (20/139;14.4%; p <0.001). Discussion  Patients with cancer should be advised to take strict precautions to reduce the risk of being infected with COVID-19. They should also be given priority for COVID-19 vaccination. If infected with COVID-19, patients with hematological malignancy and uncontrolled cancer are at higher risk of morbidity and mortality. When they are being treated (OPD or inpatient basis), additional precautions are necessary to ensure their exposure to potential COVID-19 virus is minimized. If they get infected with COVID-19, they should be given aggressive treatment to prevent complications, especially thromboembolic episodes. If they develop any thromboembolic complication, their risk of dying are significantly higher, and management should be modified accordingly. Thieme Medical and Scientific Publishers Private Ltd 2021-01 2021-08-21 /pmc/articles/PMC8380150/ /pubmed/34430515 http://dx.doi.org/10.1055/s-0041-1731910 Text en MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Hingmire, Sachin
Wategaonkar, Ravikumar
Hegde, Sujai
Mekha, Mangesh
Kulkarni, Rahul
Rajbhoj, Ashwin
Deshmukh, Chetan
Kulkarni, Padmaj
Patil, Tushar
Kanitkar, Gajanan
Wanjarkhedkar, Pankaj
Mane, Anupama
Bokil, Kamlesh
Parasnis, Amit
Gawande, Jayant
Bhatia, Jatin
Khaladkar, Bhagyashree
Sirsath, Nagesh
Melinkeri, Sameer
Kashyapi, Bhalchandra
Agrawal, Rakesh Kumar
Prabhakaran, Anushree
Desai, Isha
Kelkar, Dhananjay
Outcome of COVID-19 Infection in Cancer Patients in Pune
title Outcome of COVID-19 Infection in Cancer Patients in Pune
title_full Outcome of COVID-19 Infection in Cancer Patients in Pune
title_fullStr Outcome of COVID-19 Infection in Cancer Patients in Pune
title_full_unstemmed Outcome of COVID-19 Infection in Cancer Patients in Pune
title_short Outcome of COVID-19 Infection in Cancer Patients in Pune
title_sort outcome of covid-19 infection in cancer patients in pune
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380150/
https://www.ncbi.nlm.nih.gov/pubmed/34430515
http://dx.doi.org/10.1055/s-0041-1731910
work_keys_str_mv AT hingmiresachin outcomeofcovid19infectionincancerpatientsinpune
AT wategaonkarravikumar outcomeofcovid19infectionincancerpatientsinpune
AT hegdesujai outcomeofcovid19infectionincancerpatientsinpune
AT mekhamangesh outcomeofcovid19infectionincancerpatientsinpune
AT kulkarnirahul outcomeofcovid19infectionincancerpatientsinpune
AT rajbhojashwin outcomeofcovid19infectionincancerpatientsinpune
AT deshmukhchetan outcomeofcovid19infectionincancerpatientsinpune
AT kulkarnipadmaj outcomeofcovid19infectionincancerpatientsinpune
AT patiltushar outcomeofcovid19infectionincancerpatientsinpune
AT kanitkargajanan outcomeofcovid19infectionincancerpatientsinpune
AT wanjarkhedkarpankaj outcomeofcovid19infectionincancerpatientsinpune
AT maneanupama outcomeofcovid19infectionincancerpatientsinpune
AT bokilkamlesh outcomeofcovid19infectionincancerpatientsinpune
AT parasnisamit outcomeofcovid19infectionincancerpatientsinpune
AT gawandejayant outcomeofcovid19infectionincancerpatientsinpune
AT bhatiajatin outcomeofcovid19infectionincancerpatientsinpune
AT khaladkarbhagyashree outcomeofcovid19infectionincancerpatientsinpune
AT sirsathnagesh outcomeofcovid19infectionincancerpatientsinpune
AT melinkerisameer outcomeofcovid19infectionincancerpatientsinpune
AT kashyapibhalchandra outcomeofcovid19infectionincancerpatientsinpune
AT agrawalrakeshkumar outcomeofcovid19infectionincancerpatientsinpune
AT prabhakarananushree outcomeofcovid19infectionincancerpatientsinpune
AT desaiisha outcomeofcovid19infectionincancerpatientsinpune
AT kelkardhananjay outcomeofcovid19infectionincancerpatientsinpune